Cancer Detection and Diagnosis Research in Oklahoma
Cancer Detection and Diagnosis Research (93.394) awarded $5.4 million to recipients in Oklahoma in 5 grants from fiscal 2021 to 2025, 0.2% of the program's national total. University of Oklahoma received the most, $4.8 million.
- Awarded in Oklahoma$5.4 million
- Awards5
- Share of the program0.2%
- Rank among states39th of 45
- National total$2.7 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 2 | $551,596 |
| FY 2022 | 2 | $486,927 |
| FY 2023 | 4 | $1.4 million |
| FY 2024 | 3 | $832,017 |
| FY 2025 | 2 | $2.1 million |
Recipients in Oklahoma
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| University of Oklahoma | Colleges and universities | 4 | $4.8 million |
| University of Oklahoma | Colleges and universities | 1 | $607,204 |
Open opportunities under this program
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
- Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
- Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)
- Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
See all 47 on the program page
Questions people ask
How much Cancer Detection and Diagnosis Research money goes to Oklahoma?
$5.4 million from fiscal 2021 to 2025, across 5 awards. Oklahoma ranks 39th of 45 states and territories for this program.
Who receives Cancer Detection and Diagnosis Research money in Oklahoma?
The largest recipient is University of Oklahoma, with $4.8 million in 4 awards. Next is University of Oklahoma.
Can organizations in Oklahoma apply now?
Yes, 47 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cancer Detection and Diagnosis Research in other states
Other large programs in Oklahoma
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- Child Care and Development Block Grant
- National School Lunch Program
- Children's Health Insurance Program
- Title I Grants to Local Educational Agencies
- Special Education Grants to States
- Head Start
- Indian Housing Block Grants